Mrs Margaretta R D Brown, RPH | |
The Village Mall Bay 8, Plot 113 Estate Barren Spot, Kingshill, VI 00850 | |
(340) 773-8309 | |
Not Available |
Full Name | Mrs Margaretta R D Brown |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | The Village Mall Bay 8, Kingshill, Virgin Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609581396 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 157 (Virgin Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Margaretta R D Brown, RPH 10574 Estate Barren Spot, Kingshill, VI 00850 Ph: (340) 773-8309 | Mrs Margaretta R D Brown, RPH The Village Mall Bay 8, Plot 113 Estate Barren Spot, Kingshill, VI 00850 Ph: (340) 773-8309 |
News Archive
The question of why we age is one of the most fascinating questions for humankind, but nothing close to a satisfactory answer has been found to date.
FDA Device Division, still concerned about mercury toxicity in American dentistry, is convening yet another professional panel review regarding safety issues. A nationwide convergence of scientists, dental and medical professionals, lead by the International Academy of Oral Medicine and Toxicology (IAOMT) are provoking new challenges to the Food and Drug Administration's (FDA) July'09 "no risk" classification of mercury fillings .
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it privately placed 357,857 common shares at a price of approximately $0.53 per share with certain members of its Board of Directors and management team.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders.
› Verified 7 days ago